These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7230010)

  • 1. The actions of xylamine on central noradrenergic neurons.
    Dudley MW; Butcher LL; Kammerer RC; Cho AK
    J Pharmacol Exp Ther; 1981 Jun; 217(3):834-40. PubMed ID: 7230010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study.
    Howard-Butcher S; Blaha CD; Lane RF
    J Pharmacol Exp Ther; 1985 Apr; 233(1):58-63. PubMed ID: 3981462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of [3H]norepinephrine uptake in organ cultured rat superior cervical ganglia by xylamine.
    Fischer JB; Cho AK
    J Pharmacol Exp Ther; 1982 Jan; 220(1):115-9. PubMed ID: 7053407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norepinephrine and neural plasticity: the effects of xylamine on experience-induced changes in brain weight, memory, and behavior.
    Benloucif S; Bennett EL; Rosenzweig MR
    Neurobiol Learn Mem; 1995 Jan; 63(1):33-42. PubMed ID: 7663878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of xylamine, a nitrogen mustard on [3H]norepinephrine accumulation in rabbit aorta.
    Cho AK; Ransom RW; Fischer JB; Kammerer RC
    J Pharmacol Exp Ther; 1980 Aug; 214(2):324-7. PubMed ID: 7391980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low dose of xylamine produces sustained and selective decreases in rat brain norepinephrine without evidence of neuronal degeneration.
    Dudley MW; Siegel BW; Ogden AM; McCarty DR
    J Pharmacol Exp Ther; 1988 Oct; 247(1):174-9. PubMed ID: 2459367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical transformations of xylamine (N-2'-chloroethyl-N-ethyl-2-methylbenzylamine) in solution. Pharmacological activity of the species derived from this irreversible norepinephrine uptake inhibitor.
    Ransom RW; Kammerer RC; Cho AK
    Mol Pharmacol; 1982 Mar; 21(2):380-6. PubMed ID: 7099142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
    Pan JT; Hooth MJ; Lookingland KJ; Moore KE; Marks TA
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):26-33. PubMed ID: 8236258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of norepinephrine from organ-cultured superior cervical ganglia: effects of the norepinephrine uptake inhibitor xylamine.
    Fischer JB; Cho AK
    J Pharmacol Exp Ther; 1983 Jun; 225(3):623-9. PubMed ID: 6864523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hypophosphatemia on brain catecholamines content in the rat.
    Bhaskaran D; Massry SG; Campese VM
    Miner Electrolyte Metab; 1987; 13(6):469-72. PubMed ID: 3696100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ibopamine and the active metabolite epinine on the catecholamine content of rat hypothalamus and brainstem in vitro.
    Scriba GK; Hower JA; Liang NY; Fennessey PV; Borchardt RT
    J Pharmacol Exp Ther; 1988 Nov; 247(2):609-16. PubMed ID: 3183957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain.
    Kostrzewa RM; Garey RE
    J Pharmacol Exp Ther; 1976 Apr; 197(1):105-18. PubMed ID: 1263125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.
    Ferris RM; Tang FL; Maxwell RA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):407-16. PubMed ID: 5033010
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of halothane on catecholamine metabolism in the brain stem of rats].
    Schulte J
    Arzneimittelforschung; 1976; 26(3):324-7. PubMed ID: 989321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins.
    Dailly E; Chenu F; Petit-Demoulière B; Bourin M
    J Neurosci Methods; 2006 Jan; 150(1):111-5. PubMed ID: 16098600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of metallothionein-I+II levels in specific brain areas and liver in the rat: role of catecholamines.
    Gasull T; Giralt M; Garcia A; Hidalgo J
    Glia; 1994 Oct; 12(2):135-43. PubMed ID: 7868187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Scalori V; Corsini GU
    Ann N Y Acad Sci; 1998 May; 844():166-77. PubMed ID: 9668674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of xylamine with peripheral sympathetic neurons.
    Ransom RW; Waggaman LA; Cho AK
    Life Sci; 1985 Sep; 37(13):1177-82. PubMed ID: 3930904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.